Balance Sheet Panacea Life Sciences Holdings, Inc.

Equities

PLSH

US69810P1093

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 10:42:46 2025-06-23 am EDT			5-day change	1st Jan Change
0.0374 ^USD	+2.19%		+2.19%	+49.60%

2024	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2024	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

9.YPdJnTfvS-o8n7dL5WuwdELDP0nJI-YHO2ho24qTkOY.DMJ96m3cAaFf-M18oC_VGCCVUjO9E5c_bSwdv-j7ooclnBnTAqUsoGbshw

Published financial data: PANACEA LIFE SCIENCES HOLDINGS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	2.2M	9.02M	2.06M	1.63M	2.38M
Total Revenues	2.2M	9.02M	2.06M	1.63M	2.38M
Cost of Goods Sold, Total	3.88M	11.47M	6.48M	6.19M	6.47M
Gross Profit	-1.68M	-2.45M	-4.42M	-4.56M	-4.09M
Selling General & Admin Expenses, Total	986K	2.81M	1.52M	1.09M	1.46M
Other Operating Expenses, Total	986K	2.81M	1.52M	1.09M	1.46M
Operating Income	-2.67M	-5.26M	-5.94M	-5.65M	-5.55M
Interest Expense, Total	-434K	-1.51M	-1.11M	-2.05M	-1.56M
Net Interest Expenses	-434K	-1.51M	-1.11M	-2.05M	-1.56M
Other Non Operating Income (Expenses)	655K	-21.71K	237K	260K	178K
EBT, Excl. Unusual Items	-2.45M	-6.79M	-6.81M	-7.44M	-6.92M
Gain (Loss) On Sale Of Investments	130K	1.43M	1.17M	-2.64M	-1.09M
Gain (Loss) On Sale Of Assets	-493K	-141K	-297K	-	-
Other Unusual Items	-	273K	1.15M	935K	748
EBT, Incl. Unusual Items	-2.81M	-5.23M	-4.78M	-9.14M	-8.02M
Earnings From Continuing Operations	-2.81M	-5.23M	-4.78M	-9.14M	-8.02M
Net Income to Company	-2.81M	-5.23M	-4.78M	-9.14M	-8.02M
Net Income - (IS)	-2.81M	-5.23M	-4.78M	-9.14M	-8.02M
Net Income to Common Incl Extra Items	-2.81M	-5.23M	-4.78M	-9.14M	-8.02M
Net Income to Common Excl. Extra Items	-2.81M	-5.23M	-4.78M	-9.14M	-8.02M
Per Share Items
Net EPS - Basic	-0.16	-0.28	-0.27	-0.62	-0.48
Basic EPS - Continuing Operations	-0.16	-0.28	-0.27	-0.62	-0.48
Basic Weighted Average Shares Outstanding	17.79M	18.63M	17.82M	14.86M	16.63M
Net EPS - Diluted	-0.16	-0.28	-0.27	-0.62	-0.48
Diluted EPS - Continuing Operations	-0.16	-0.28	-0.27	-0.62	-0.48
Diluted Weighted Average Shares Outstanding	17.79M	18.63M	17.82M	14.86M	16.63M
Normalized Basic EPS	-0.09	-0.23	-0.24	-0.31	-0.26
Normalized Diluted EPS	-0.09	-0.23	-0.24	-0.31	-0.26
Supplemental Items
EBITDA	-1.87M	-3.57M	-4.2M	-3.92M	-3.83M
EBITA	-2.61M	-5.2M	-5.88M	-5.59M	-5.55M
EBIT	-2.67M	-5.26M	-5.94M	-5.65M	-5.55M
EBITDAR	-1.42M	-3.11M	-3.74M	-3.46M	-3.27M
Normalized Net Income	-1.53M	-4.24M	-4.25M	-4.65M	-4.33M
Interest on Long-Term Debt	434K	-	-	-	-
Supplemental Operating Expense Items
Advertising Expense	255K	1.5M	378K	209K	17.95K
Selling and Marketing Expenses	255K	1.5M	378K	209K	17.95K
General and Administrative Expenses	731K	1.3M	1.14M	884K	1.44M
Net Rental Expense, Total	459K	459K	459K	459K	561K
Imputed Operating Lease Interest Expense	-	266K	214K	443K	344K
Imputed Operating Lease Depreciation	-	192K	245K	16.11K	217K
Stock-Based Comp., Other (Total)	-	-	-	55K	-
Total Stock-Based Compensation	-	-	-	55K	-

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	8.52M	84.38K	19.77K	6.95K	101K
Short Term Investments	1.43M	2.85M	3.79M	1.11M	14.93K
Total Cash And Short Term Investments	9.94M	2.94M	3.81M	1.11M	116K
Accounts Receivable, Total	299K	147K	244K	206K	264K
Other Receivables	-	-	500K	500K	-
Total Receivables	299K	147K	744K	706K	264K
Inventory	3.36M	8.41M	4.26M	4.45M	4.01M
Prepaid Expenses	991K	27.38K	278K	113K	263K
Total Current Assets	14.59M	11.52M	9.1M	6.38M	4.66M
Gross Property Plant And Equipment	15.74M	20.03M	16.3M	16.44M	17.55M
Accumulated Depreciation	-884K	-2.5M	-3.86M	-5.52M	-7.24M
Net Property Plant And Equipment	14.86M	17.53M	12.44M	10.92M	10.31M
Goodwill	2.19M	2.19M	2.19M	2.19M	3.01M
Other Intangibles, Total	184K	123K	61.4K	-	-
Total Assets	31.82M	31.36M	23.78M	19.49M	17.98M
Liabilities
Accounts Payable, Total	1.11M	1.77M	1.69M	2.67M	4.63M
Short-term Borrowings	-	273K	319K	446K	507K
Current Portion of Long-Term Debt	13.16M	15.06M	6.44M	9.87M	11.4M
Current Portion of Leases	707K	1.16M	1.62M	2.09M	2.91M
Total Current Liabilities	14.97M	18.26M	10.07M	15.07M	19.45M
Long-Term Debt	885K	2.7M	3.26M	3.57M	3.57M
Long-Term Leases	4.02M	3.69M	3.35M	2.99M	3.25M
Total Liabilities	19.88M	24.65M	16.68M	21.63M	26.27M
Preferred Stock Convertible	52.33K	52.33K	853	852	1.24K
Total Preferred Equity	52.33K	52.33K	853	852	1.24K
Common Stock, Total	186K	186K	1.41K	1.5K	1.76K
Additional Paid In Capital	18.45M	18.45M	23.87M	23.76M	25.63M
Retained Earnings	-6.75M	-11.98M	-16.77M	-25.91M	-33.92M
Total Common Equity	11.89M	6.66M	7.1M	-2.15M	-8.29M
Total Equity	11.94M	6.71M	7.1M	-2.14M	-8.29M
Total Liabilities And Equity	31.82M	31.36M	23.78M	19.49M	17.98M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	17.79M	18.63M	14.76M	14.76M	17.65M
ECS Total Common Shares Outstanding	17.79M	18.63M	14.07M	14.97M	17.65M
Book Value / Share	0.67	0.36	0.5	-0.14	-0.47
Tangible Book Value	9.51M	4.34M	4.85M	-4.33M	-11.31M
Tangible Book Value Per Share	0.53	0.23	0.34	-0.29	-0.64
Total Debt	18.77M	22.89M	15M	18.97M	21.65M
Net Debt	8.83M	19.95M	11.18M	17.85M	21.53M
Debt Equivalent Oper. Leases	3.67M	3.67M	3.67M	3.67M	4.49M
Account Code - Inventory Valuation	-	6	-	6	-
Inventories - Raw Materials, Total	712K	1.01M	986K	891K	880K
Inventories - Work In Process, Total	1.4M	1.37M	1.47M	1.86M	1.87M
Inventories - Finished Goods, Total	1.25M	6.02M	1.81M	1.69M	1.26M
Land - (BS)	2.15M	2.29M	92.22K	92.22K	92.22K
Machinery, Total	7.77M	11.54M	11.1M	11.6M	11.78M
Full Time Employees	-	-	29	19	40
Part Time Employees	-	-	6	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-2.81M	-5.23M	-4.78M	-9.14M	-8.02M
Depreciation & Amortization - CF	733K	1.63M	1.68M	1.67M	1.71M
Amortization of Goodwill and Intangible Assets - (CF)	61.4K	61.4K	61.4K	61.4K	-
Depreciation & Amortization, Total	794K	1.69M	1.74M	1.73M	1.71M
Amortization of Deferred Charges, Total - (CF)	-	-	118K	1.07M	38.33K
(Gain) Loss From Sale Of Asset	493K	141K	297K	-	-
(Gain) Loss on Sale of Investments - (CF)	-130K	-1.43M	-1.17M	2.64M	1.09M
Other Operating Activities, Total	-233K	-	-756K	-254K	614K
Change In Accounts Receivable	-145K	152K	-97.19K	38.37K	431K
Change In Inventories	-2.92M	-5.05M	-548K	-184K	297K
Change In Accounts Payable	811K	655K	1.07M	1.08M	1.99M
Change in Other Net Operating Assets	252K	1.42M	208K	624K	318K
Cash from Operations	-3.89M	-7.65M	-3.92M	-2.4M	-1.52M
Capital Expenditure	-6.98M	-3.2M	-163K	-244K	-65.32K
Sale of Property, Plant, and Equipment	-	120K	446K	-	-
Cash Acquisitions	-	-	9.16K	-	-
Investment in Marketable and Equity Securities, Total	-	-	230K	46.83K	-
Cash from Investing	-6.98M	-3.08M	523K	-197K	-65.32K
Short Term Debt Issued, Total	15.73M	6.26M	3.55M	4.34M	293K
Long-Term Debt Issued, Total	-	-	-	-	1.8M
Total Debt Issued	15.73M	6.26M	3.55M	4.34M	2.09M
Short Term Debt Repaid, Total	-2.58M	-3.96M	-	-	-
Long-Term Debt Repaid, Total	-	-	-211K	-1.76M	-407K
Total Debt Repaid	-2.58M	-3.96M	-211K	-1.76M	-407K
Issuance of Common Stock	365K	-	-	-	-
Issuance of Preferred Stock	5M	-	-	-	-
Cash from Financing	18.52M	2.3M	3.33M	2.58M	1.68M
Miscellaneous Cash Flow Adjustments	-	-	-1	-	-
Net Change in Cash	7.65M	-8.43M	-64.6K	-12.82K	93.97K
Supplemental Items
Cash Interest Paid	-	583K	-	-	-
Levered Free Cash Flow	-	-9.02M	508K	-1.2M	-61.83K
Unlevered Free Cash Flow	-	-8.07M	1.08M	-991K	872K
Change In Net Working Capital	-	3.28M	-3.22M	-999K	-2.69M
Net Debt Issued / Repaid	13.16M	2.3M	3.33M	2.58M	1.68M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	-10.4	-13.46	-16.33	-18.5
Return on Total Capital	-	-10.9	-14.36	-18.15	-22.97
Return On Equity %	-	-56.11	-69.26	-368.81	153.61
Return on Common Equity	-	-56.43	-69.26	-368.94	153.58
Margin Analysis
Gross Profit Margin %	-76.56	-27.19	-214.53	-280.21	-171.48
SG&A Margin	44.86	31.12	73.74	67.2	61.07
EBITDA Margin %	-85.28	-39.54	-203.92	-241.01	-160.72
EBITA Margin %	-118.62	-57.62	-285.28	-343.63	-232.55
EBIT Margin %	-121.42	-58.31	-288.26	-347.41	-232.55
Income From Continuing Operations Margin %	-127.88	-58.02	-232.2	-561.94	-336.08
Net Income Margin %	-127.88	-58.02	-232.2	-561.94	-336.08
Net Avail. For Common Margin %	-127.88	-58.02	-232.2	-561.94	-336.08
Normalized Net Income Margin	-69.6	-47.07	-206.53	-285.83	-181.44
Levered Free Cash Flow Margin	-	-100.01	24.67	-73.99	-2.59
Unlevered Free Cash Flow Margin	-	-89.53	52.5	-60.91	36.57
Asset Turnover
Asset Turnover	-	0.29	0.07	0.08	0.13
Fixed Assets Turnover	-	0.56	0.14	0.14	0.22
Receivables Turnover (Average Receivables)	-	40.41	10.51	7.22	10.15
Inventory Turnover (Average Inventory)	-	1.95	1.02	1.42	1.53
Short Term Liquidity
Current Ratio	0.97	0.63	0.9	0.42	0.24
Quick Ratio	0.68	0.17	0.45	0.12	0.02
Operating Cash Flow to Current Liabilities	-0.26	-0.42	-0.39	-0.16	-0.08
Days Sales Outstanding (Average Receivables)	-	9.06	34.72	50.55	35.97
Days Outstanding Inventory (Average Inventory)	-	187.79	357.05	257.06	238.52
Average Days Payable Outstanding	-	31.86	270	124.68	220.46
Cash Conversion Cycle (Average Days)	-	164.99	121.76	182.93	54.04
Long Term Solvency
Total Debt/Equity	157.2	341.19	211.13	-884.47	-261.06
Total Debt / Total Capital	61.12	77.33	67.86	112.75	162.09
LT Debt/Equity	41.11	95.27	93.07	-305.9	-82.34
Long-Term Debt / Total Capital	15.98	21.59	29.91	38.99	51.12
Total Liabilities / Total Assets	62.48	78.61	70.14	111	146.11
EBIT / Interest Expense	-6.15	-3.48	-5.37	-2.76	-3.56
EBITDA / Interest Expense	-3.26	-2.06	-3.38	-1.69	-2.1
(EBITDA - Capex) / Interest Expense	-19.33	-4.17	-3.53	-1.81	-2.15
Total Debt / EBITDA	-13.26	-7.37	-4.01	-5.48	-6.61
Net Debt / EBITDA	-6.23	-6.42	-2.99	-5.16	-6.58
Total Debt / (EBITDA - Capex)	-2.24	-3.63	-3.84	-5.12	-6.48
Net Debt / (EBITDA - Capex)	-1.05	-3.16	-2.86	-4.82	-6.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	310.19	-77.16	-21.01	46.59
Gross Profit, 1 Yr. Growth %	-	45.67	80.21	3.18	-10.29
EBITDA, 1 Yr. Growth %	-	90.2	17.78	-6.64	-2.24
EBITA, 1 Yr. Growth %	-	99.26	13.07	-4.85	-0.8
EBIT, 1 Yr. Growth %	-	96.98	12.92	-4.8	-1.88
Earnings From Cont. Operations, 1 Yr. Growth %	-	86.1	-8.59	91.17	-12.33
Net Income, 1 Yr. Growth %	-	86.1	-8.59	91.17	-12.33
Normalized Net Income, 1 Yr. Growth %	-	177.38	4.42	9.33	-6.95
Diluted EPS Before Extra, 1 Yr. Growth %	-	75.51	-13.23	129.23	-21.64
Accounts Receivable, 1 Yr. Growth %	-	-50.73	65.98	-15.69	28.06
Inventory, 1 Yr. Growth %	-	150.29	-49.29	4.33	-9.78
Net Property, Plant and Equip., 1 Yr. Growth %	-	17.99	-29.06	-12.2	-5.55
Total Assets, 1 Yr. Growth %	-	-1.44	-24.16	-18.06	-7.73
Tangible Book Value, 1 Yr. Growth %	-	-54.34	10.34	-189.34	160.88
Common Equity, 1 Yr. Growth %	-	-44.01	5.86	-130.21	286.53
Cash From Operations, 1 Yr. Growth %	-	96.64	-48.71	-38.82	-36.47
Capital Expenditures, 1 Yr. Growth %	-	-54.16	-94.91	49.62	-73.21
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-105.63	-336.91	-95.09
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-113.39	-191.64	-183.39
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-3.21	-57.52	7.61
Gross Profit, 2 Yr. CAGR %	-	-	62.03	36.36	-3.79
EBITDA, 2 Yr. CAGR %	-	-	49.68	4.86	-4.47
EBITA, 2 Yr. CAGR %	-	-	50.1	3.73	-2.85
EBIT, 2 Yr. CAGR %	-	-	49.14	3.68	-3.35
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	30.43	32.19	29.46
Net Income, 2 Yr. CAGR %	-	-	30.43	32.19	29.46
Normalized Net Income, 2 Yr. CAGR %	-	-	66.73	6.84	0.86
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	29.51	41.03	34.02
Accounts Receivable, 2 Yr. CAGR %	-	-	-9.57	18.29	3.91
Inventory, 2 Yr. CAGR %	-	-	12.66	-27.27	-2.98
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-8.51	-21.08	-8.93
Total Assets, 2 Yr. CAGR %	-	-	-13.55	-21.17	-13.04
Tangible Book Value, 2 Yr. CAGR %	-	-	-28.59	-0.71	52.67
Common Equity, 2 Yr. CAGR %	-	-	-22.71	-43.45	8.06
Cash From Operations, 2 Yr. CAGR %	-	-	0.43	-43.98	-37.66
Capital Expenditures, 2 Yr. CAGR %	-	-	-84.72	-72.4	-36.68
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-63.47	-65.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-64.97	-10.19
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-9.55	-35.81
Gross Profit, 3 Yr. CAGR %	-	-	-	39.4	18.6
EBITDA, 3 Yr. CAGR %	-	-	-	27.89	2.44
EBITA, 3 Yr. CAGR %	-	-	-	28.94	2.19
EBIT, 3 Yr. CAGR %	-	-	-	28.41	1.8
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	48.16	15.28
Net Income, 3 Yr. CAGR %	-	-	-	48.16	15.28
Normalized Net Income, 3 Yr. CAGR %	-	-	-	44.85	2.03
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	56.66	15.94
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-11.66	21.46
Inventory, 3 Yr. CAGR %	-	-	-	9.81	-21.85
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-9.76	-16.21
Total Assets, 3 Yr. CAGR %	-	-	-	-15.08	-16.92
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-23.06	37.01
Common Equity, 3 Yr. CAGR %	-	-	-	-43.49	7.32
Cash From Operations, 3 Yr. CAGR %	-	-	-	-14.86	-41.58
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-67.31	-72.67
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-81
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-52.37